These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29518380)

  • 1. Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
    Ahmad F; Leake DS
    Chem Phys Lipids; 2018 Jul; 213():13-24. PubMed ID: 29518380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein oxidation by ferritin at lysosomal pH.
    Ojo OO; Leake DS
    Chem Phys Lipids; 2018 Dec; 217():51-57. PubMed ID: 30287220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
    Wen Y; Ahmad F; Mohri Z; Weinberg PD; Leake DS
    Atherosclerosis; 2019 Dec; 291():9-18. PubMed ID: 31629988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages.
    Ahmad F; Leake DS
    J Lipid Res; 2019 Jan; 60(1):98-110. PubMed ID: 30397186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamins E and C do not effectively inhibit low density lipoprotein oxidation by ferritin at lysosomal pH.
    Ojo OO; Leake DS
    Free Radic Res; 2021 May; 55(5):525-534. PubMed ID: 34396869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
    Satchell L; Leake DS
    Biochemistry; 2012 May; 51(18):3767-75. PubMed ID: 22493939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin E on low density lipoprotein oxidation at lysosomal pH.
    Alboaklah HKM; Leake DS
    Free Radic Res; 2020 Sep; 54(8-9):574-584. PubMed ID: 32938237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromium and human low-density lipoprotein oxidation.
    Lapenna D; Ciofani G
    J Trace Elem Med Biol; 2020 May; 59():126411. PubMed ID: 32058272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
    Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
    Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ
    Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipoprotein lipid oxidation.
    Cynshi O; Stocker R
    Handb Exp Pharmacol; 2005; (170):563-90. PubMed ID: 16596815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases.
    Santanam N; Parthasarathy S
    J Clin Invest; 1995 Jun; 95(6):2594-600. PubMed ID: 7769102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
    Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
    J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins.
    Plane F; Jacobs M; McManus D; Bruckdorfer KR
    Atherosclerosis; 1993 Oct; 103(1):73-9. PubMed ID: 8280187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.
    Iuliano L; Colavita AR; Camastra C; Bello V; Quintarelli C; Alessandroni M; Piovella F; Violi F
    Br J Pharmacol; 1996 Dec; 119(7):1438-46. PubMed ID: 8968553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.